Wei Dong Jiang
Fondateur chez SHANGHAI HENLIUS BIOTECH, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Wei Dong Jiang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Directeur Technique/Scientifique/R&D | 01/12/2009 | - |
| Fondateur | 01/12/2009 | - |
Historique de carrière de Wei Dong Jiang
Anciens postes connus de Wei Dong Jiang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Directeur Technique/Scientifique/R&D | 01/01/2009 | - |
| Fondateur | 01/01/2009 | - |
Formation de Wei Dong Jiang
| Zhejiang University | Undergraduate Degree |
| University of Giessen | Doctorate Degree |
Statistiques
Internationale
| Chine | 3 |
| Etats-Unis | 2 |
| Allemagne | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Bourse
- Insiders
- Wei Dong Jiang
- Expérience
